It is a test that detects antibodies against the Hepatitis B surface antigen (HBsAg) to assess immunity to Hepatitis B.

It is recommended after Hepatitis B vaccination, recovery from Hepatitis B, or as part of routine screening.

No special preparation is required. Inform your healthcare provider of any recent vaccinations or Hepatitis B history.

Results are usually available within 24 to 48 hours after the blood sample is collected.

Positive results indicate immunity to Hepatitis B, while negative results may suggest the need for further evaluation or vaccination.

The test involves collecting a small blood sample, usually through a finger prick or venous draw, and testing it for malaria antigens.

Rapid diagnostic tests (RDTs) can detect antigens specific to Plasmodium falciparum, Plasmodium vivax, or both, depending on the test used.

Yes, RDTs are generally reliable for detecting malaria antigens, with high specificity and sensitivity when performed correctly.

Some RDTs can differentiate between P. falciparum and other malaria species, aiding in targeted treatment strategies.

The test involves a simple blood draw with minimal risks, such as minor bruising at the puncture site.

Conditions such as brain tumors, aneurysms, epilepsy, and arteriovenous malformations can be treated using craniotomy.